WENDY DONAUGH: Open Payments
NPI 1336523836 · BILLINGS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 38 payments from 10 companies in 2025. Trend: 2023 $533 · 2024 $603 · 2025 $633
Food & beverage: $618Education: $15
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $151 |
| ABBVIE INC. | 9 | $135 |
| Alexion Pharmaceuticals, Inc. | 5 | $110 |
| ANI Pharmaceuticals, Inc. | 4 | $69 |
| Janssen Biotech, Inc. | 2 | $41 |
| UCB, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: STRENSIQ, RINVOQ, Otezla, PURIFIED CORTROPHIN GEL, EVENITY, TREMFYA, SKYRIZI, Bimzelx.
Industry payments across MT — which companies pay providers there.
